INS and Alzheimer disease: Furthermore, AD-associated neuropathologies—including extracellular amyloid-β (Aβ) plaques—may exacerbate cerebral insulin resistance, suggesting the presence of a bidirectional feedback loop in which amyloid accumulation and insulin signaling deficits reinforce one another [17,18,19,20].